The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Francois Eric | Director | Grant(A) | 1.8M | — | $0 |
| Jan 7, 2026 | Pierce Kristen | Chief Development Officer | Grant(A) | 1.6M | — | $0 |
| Jan 7, 2026 | Patel Shami | Director | Grant(A) | 691K | — | $0 |
| Jan 7, 2026 | Laporte Kathleen | Director | Grant(A) | 691K | — | $0 |
| Jan 7, 2026 | Kucharchuk Andrew Albert | Chief Financial Officer | Grant(A) | 1.2M | — | $0 |
| Jan 7, 2026 | Rolfe Lindsey | Director | Grant(A) | 691K | — | $0 |
| Jan 7, 2026 | Byrnes Michael | Director | Grant(A) | 691K | — | $0 |
| Jan 7, 2026 | Atwood Brian G | Director | Grant(A) | 1.6M | — | $0 |
| Jan 7, 2026 | Ehrlich Christopher B | Chairman and CEO, Director | Grant(A) | 4.5M | — | $0 |
| May 30, 2025 | Kucharchuk Andrew Albert | Chief Financial Officer | Grant(A) | 153K | — | $0 |
| May 30, 2025 | Pierce Kristen | Chief Development Officer | Grant(A) | 155K | — | $0 |
| May 30, 2025 | Atwood Brian G | Director | Grant(A) | 123K | — | $0 |
| May 30, 2025 | Ehrlich Christopher B | Chairman and CEO, Director | Grant(A) | 62K | — | $0 |
| May 30, 2025 | Patel Shami | Director | Grant(A) | 12K | — | $0 |
| May 30, 2025 | Rolfe Lindsey | Director | Grant(A) | 9K | — | $0 |
| May 30, 2025 | Byrnes Michael | Director | Grant(A) | 9K | — | $0 |
| May 30, 2025 | Laporte Kathleen | Director | Grant(A) | 9K | — | $0 |
| Mar 31, 2025 | Atwood Brian G | Director | Option exercise(M) | 294K | — | $0 |
| Mar 31, 2025 | Atwood Brian G | Director | Option exercise(M) | 294K | — | $0 |
| Mar 4, 2025 | Ehrlich Christopher B | Chairman and CEO, Director | Grant(A) | 119K | — | $0 |
| Mar 4, 2025 | Atwood Brian G | Director | Grant(A) | 15K | — | $0 |
| Mar 4, 2025 | Patel Shami | Director | Grant(A) | 15K | — | $0 |
| Mar 4, 2025 | Byrnes Michael | Director | Grant(A) | 18K | — | $0 |
| Mar 4, 2025 | Rolfe Lindsey | Director | Grant(A) | 18K | — | $0 |
| Mar 4, 2025 | Laporte Kathleen | Director | Grant(A) | 18K | — | $0 |
| Feb 24, 2025 | Atwood Brian G | Director | Grant(A) | 254K | — | $0 |
| Feb 24, 2025 | Byrnes Michael | Director | Grant(A) | 128K | — | $0 |
| Feb 24, 2025 | Ehrlich Christopher B | Chairman and CEO, Director | Grant(A) | 1.3M | — | $0 |
| Feb 24, 2025 | Laporte Kathleen | Director | Grant(A) | 128K | — | $0 |
| Feb 24, 2025 | Patel Shami | Director | Grant(A) | 128K | — | $0 |
| Feb 24, 2025 | Rolfe Lindsey | Director | Grant(A) | 128K | — | $0 |
| Feb 7, 2025 | Atwood Brian G | Director | Grant(A) | 306K | — | $0 |
| Feb 7, 2025 | Atwood Brian G | Director | Grant(A) | 204K | $1.96 | $400K |
| Feb 7, 2025 | Atwood Brian G | Director | Grant(A) | 306K | $1.96 | $600K |
| Feb 7, 2025 | Atwood Brian G | Director | Grant(A) | 204K | — | $0 |
| Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | Sell(S) | 3.0M | $0.06 | $180K |
| Dec 12, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | Sell(S) | 1.6M | $0.07 | $113K |
| Dec 11, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | Sell(S) | 1.3M | $0.08 | $108K |
| Dec 10, 2024 | Kossar Mitchell William | 10% Owner | Sell(S) | 1.6M | $0.09 | $141K |
| Dec 9, 2024 | Kossar Mitchell William | 10% Owner | Sell(S) | 851K | $0.11 | $94K |
| Dec 6, 2024 | Kossar Mitchell William | 10% Owner | Sell(S) | 1.2M | $0.12 | $148K |
| Dec 2, 2024 | Patel Shami | Director | Grant(A) | 128K | — | $0 |
| Dec 2, 2024 | Atwood Brian G | Director | Grant(A) | 254K | — | $0 |
| Dec 2, 2024 | Byrnes Michael | Director | Grant(A) | 128K | — | $0 |
| Dec 2, 2024 | Laporte Kathleen | Director | Grant(A) | 128K | — | $0 |
| Dec 2, 2024 | Rolfe Lindsey | Director | Grant(A) | 128K | — | $0 |
| Dec 2, 2024 | Ehrlich Christopher B | Chairman and CEO, Director | Grant(A) | 1.3M | — | $0 |
| Oct 10, 2024 | Kossar Mitchell William | 10% Owner | Sell(S) | 3.3M | $0.10 | $325K |
| Oct 1, 2024 | Pierce Kristen | Chief Development Officer | Grant(A) | 200K | — | $0 |
| Oct 1, 2024 | Kucharchuk Andrew Albert | Chief Financial Officer | Grant(A) | 500K | — | $0 |
| Sep 30, 2024 | Atwood Brian G | Director | Disposed to issuer(D) | 14K | — | $0 |
| Sep 30, 2024 | Atwood Brian G | Director | Disposed to issuer(D) | 1.3M | — | $0 |
| Sep 30, 2024 | Ehrlich Christopher B | Interim Chairman and CEO, Director | Disposed to issuer(D) | 572K | — | $0 |
| Sep 25, 2024 | Atwood Brian G | Director | Option exercise(M) | 19.4M | — | — |
| Sep 25, 2024 | Atwood Brian G | Director | Option exercise(M) | 1K | $1,000.00 | $1.0M |
| Sep 25, 2024 | Ehrlich Christopher B | Interim Chairman and CEO, Director | Option exercise(M) | 5.3M | — | — |
| Sep 25, 2024 | Ehrlich Christopher B | Interim Chairman and CEO, Director | Option exercise(M) | 275 | $1,000.00 | $275K |
| Sep 25, 2024 | Laporte Kathleen | Director | Option exercise(M) | 966K | — | — |
| Sep 25, 2024 | Laporte Kathleen | Director | Option exercise(M) | 50 | $1,000.00 | $50K |
| Sep 25, 2024 | Sloan Stuart M | 10% Owner | Sell(S) | 532K | $0.10 | $53K |
| Jun 28, 2024 | Carter Charles Ross | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Mar 25, 2024 | Atwood Brian G | Chief Executive Officer, Director | Grant(A) | 1.3M | — | $0 |
| Mar 25, 2024 | Byrnes Michael | Director | Grant(A) | 113K | — | $0 |
| Mar 25, 2024 | Carter Charles Ross | Chief Financial Officer | Grant(A) | 395K | — | $0 |
| Mar 25, 2024 | Corey Daniel | Chief Technical Officer, Director | Grant(A) | 857K | — | $0 |
| Mar 25, 2024 | Ehrlich Christopher B | Director | Grant(A) | 572K | — | $0 |
| Mar 25, 2024 | Laporte Kathleen | Director | Grant(A) | 113K | — | $0 |
| Mar 25, 2024 | Rapaport Robyn | Director | Grant(A) | 113K | — | $0 |
| Mar 25, 2024 | Rolfe Lindsey | Director | Grant(A) | 113K | — | $0 |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 1.1M | — | — |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 4.2M | — | — |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 479K | — | — |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 4K | — | — |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 5K | — | $0 |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 350K | — | $0 |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 175 | $1,000.00 | $175K |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Other(J) | 2K | $1,000.00 | $1.6M |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Option exercise(M) | 2K | $1,000.00 | $1.6M |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Option exercise(M) | 0 | — | $0 |
| Feb 14, 2024 | Ehrlich Christopher B | Director | Grant(A) | 100 | $1,000.00 | $100K |
| Feb 14, 2024 | Phoenix Biotech Sponsor, LLC | 10% Owner | Other(J) | 1.1M | — | — |
| Feb 14, 2024 | Phoenix Biotech Sponsor, LLC | 10% Owner | Other(J) | 4.2M | — | — |
| Feb 14, 2024 | Phoenix Biotech Sponsor, LLC | 10% Owner | Option exercise(M) | 0 | — | $0 |
| Feb 14, 2024 | Phoenix Biotech Sponsor, LLC | 10% Owner | Option exercise(M) | 2K | $1,000.00 | $1.6M |
| Feb 14, 2024 | Phoenix Biotech Sponsor, LLC | 10% Owner | Other(J) | 350K | — | $0 |
| Feb 14, 2024 | Phoenix Biotech Sponsor, LLC | 10% Owner | Other(J) | 2K | $1,000.00 | $1.6M |
| Feb 14, 2024 | Fisher Douglas Carl | President | Other(J) | 43K | — | — |
| Feb 14, 2024 | Fisher Douglas Carl | President | Grant(A) | 50 | $1,000.00 | $50K |
| Feb 14, 2024 | Fisher Douglas Carl | President | Other(J) | 5K | — | $0 |
| Feb 14, 2024 | Geffken Daniel E. | Chief Financial Officer | Other(J) | 10K | — | — |
| Feb 14, 2024 | Kosacz Barbara | Director | Other(J) | 6K | — | — |
| Feb 14, 2024 | Loewy Caroline M | Director | Other(J) | 6K | — | — |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Other(J) | 101K | — | — |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Other(J) | 148K | — | — |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Grant(A) | 1K | $1,000.00 | $1.0M |
| Feb 14, 2024 | Laporte Kathleen | Director | Grant(A) | 50 | $1,000.00 | $50K |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Other(J) | 101K | — | — |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Other(J) | 148K | — | — |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Grant(A) | 14K | — | $0 |
| Feb 14, 2024 | Atwood Brian G | Chief Executive Officer, Director | Grant(A) | 1K | $1,000.00 | $1.0M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).